Five Year outcomes for Triple Negative Breast Cancer: A single centre experience.

被引：0
|
作者：
Doyle, R. [1 ]
机构：
[1] Univ Hosp Limerick, Dept Breast Surg, Limerick, Ireland
来源：
IRISH JOURNAL OF MEDICAL SCIENCE | 2019年 / 188卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S62 / S62
页数：1
相关论文
共 50 条
  • [21] DGF in steroid avoidance protocal and impact on various outcomes at 1 year, a single centre experience.
    Cherukuri, Aravind
    Border, David
    Richardson, Kathleen
    Menon, Krishna
    Ahmed, Niaz
    Newstead, Chas
    Baker, Richard
    Lewington, Andrew
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 452 - 452
  • [22] Split liver transplantation: A 16 year single centre experience.
    Battula, Narendra R.
    Chava, Srinivas P.
    Madanur, Mansoor A.
    Azam, Muhammad O.
    Jassem, Wayel
    Melendez, Hector Vilca
    Srinivasan, Parthi
    Prachalias, Andreas
    Muiesan, Paolo
    Bowles, Matthew
    Heaton, Nigel
    Rela, Mohamed
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 271 - 272
  • [23] Real-world outcomes of systemic therapy for advanced triple-negative breast cancer: a tertiary centre experience
    Zhang, Shuai
    Coriano, Matilde
    Mac Eochagain, Colm
    Yang, Dorothy
    Yiu, Daniel
    Ring, Alistair
    Battisti, Nicolo M. L.
    CANCER RESEARCH, 2024, 84 (09)
  • [24] Efficacy and safety of eribulin in patients with triple negative metastatic breast cancer: Real life experience.
    Manikhas, Alexey
    Kovalenko, Elena
    Manzyuk, Valentina
    Bolotina, Larisa V.
    Zhilyaeva, Larisa
    Karabina, Elena
    Ponomarenko, Dmitry
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [25] Treatment, outcomes and prognostic factors of angiosarcoma of breast: A 25 year single institution experience.
    Ammannagari, Nischala
    Attwood, Kristopher
    Cheney, Richard
    Young, Jessica S.
    Kane, John Michael
    Salerno, Kilian Elizabeth
    Opyrchal, Mateusz
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [26] Outcomes of neoadjuvant (NA) and adjuvant (A) chemotherapy in geriatric patients with stage I-III triple-negative breast cancer (TNBC): A single institution experience.
    Sam, Christine
    Sehovic, Marina
    Extermann, Martine
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [27] Neuroendocrine breast cancer: A single center experience.
    Tasdemir, Vildan
    Kertmen, Neyran
    Cenoli, Alma
    Keskin, Ozge
    Karakas, Yusuf
    Diker, Omer
    Dizdar, Omer
    Aksoy, Sercan
    Ozisik, Yavuz
    Altundag, Kadri
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [28] “An addendum to breast cancer”: the triple negative experience
    Yasemin E. Turkman
    Holly Powell Kennedy
    Lyndsay N. Harris
    M. Tish Knobf
    Supportive Care in Cancer, 2016, 24 : 3715 - 3721
  • [29] "An addendum to breast cancer": the triple negative experience
    Turkman, Yasemin E.
    Kennedy, Holly Powell
    Harris, Lyndsay N.
    Knobf, M. Tish
    SUPPORTIVE CARE IN CANCER, 2016, 24 (09) : 3715 - 3721
  • [30] A single-centre audit of use of neoadujvant chemotherapy in triple negative breast cancer
    Parks, R.
    Hatt, J.
    Woodings, P.
    BRITISH JOURNAL OF SURGERY, 2018, 105 : 79 - 79
12345